Royce & Associates LP Sells 581,228 Shares of Bath & Body Works, Inc. $BBWI

Royce & Associates LP reduced its stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 50.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 573,951 shares of the company’s stock after selling 581,228 shares during the quarter. Royce & Associates LP’s holdings in Bath & Body Works were worth $11,525,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of BBWI. American Century Companies Inc. grew its stake in shares of Bath & Body Works by 2,204.1% during the third quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares during the last quarter. Jupiter Asset Management Ltd. boosted its stake in Bath & Body Works by 553.2% in the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after acquiring an additional 3,145,797 shares during the last quarter. Bank of America Corp DE boosted its stake in Bath & Body Works by 86.9% in the third quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock valued at $87,568,000 after acquiring an additional 1,580,176 shares during the last quarter. Two Sigma Investments LP boosted its stake in Bath & Body Works by 1,004.1% in the third quarter. Two Sigma Investments LP now owns 1,443,312 shares of the company’s stock valued at $37,180,000 after acquiring an additional 1,312,586 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new position in Bath & Body Works in the third quarter valued at approximately $31,942,000. 95.14% of the stock is owned by institutional investors.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

Wall Street Analyst Weigh In

A number of brokerages have issued reports on BBWI. Telsey Advisory Group raised their price objective on shares of Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a research note on Thursday, March 5th. Piper Sandler began coverage on shares of Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective on the stock. Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price objective for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Barclays raised their price objective on shares of Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research note on Monday, March 2nd. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Tuesday, March 3rd. Three equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $21.21.

Check Out Our Latest Research Report on BBWI

Bath & Body Works Stock Up 10.3%

Shares of NYSE BBWI opened at $19.56 on Thursday. The company’s fifty day moving average is $18.65 and its 200-day moving average is $20.24. The stock has a market cap of $3.94 billion, a price-to-earnings ratio of 6.21, a P/E/G ratio of 1.76 and a beta of 1.43. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $33.96.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, research analysts anticipate that Bath & Body Works, Inc. will post 2.61 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is currently 25.40%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.